Abstract
Micro-TESE (Testicular Sperm Extraction), a procedure performed for treatment of Non-Obstructive Azoospermia, a leading infertility issue among males globally accounting for about 7% of the male population. Azoospermia is the absence of sperms in ejaculate upon semen analysis, 2% of the global population has encountered. A lot is discussed upon sperm retrieval success in both variants of Micro-TESE, which are Transverse or horizontal and longitudinal or vertical approaches, established studies have identified about 45% to 65% of success retrieving spermatozoa. The objective is the identification of the success of both the variants of procedure separately and also of postop complications to both approaches for micro-TESE. A cohort study, for which data, secondary (retrospective), was obtained from King Abdulaziz Medical City (KAMC), Riyadh. The time frame for data covered January 2016 to November 2018; 87 patients underwent micro-TESE, as in the logbook available in “Best Care System at KAMC. Data obtained was analyzed using SPSS Software, 87 of these patients who underwent micro-TESE procedure, 45 were done with the transverse approach and 42 with longitudinal approach, accounting for 51.7% and 48.3%, respectively. Upon postop evaluation, in the transverse approach, sperm were retrieved in 25.29% and for the longitudinal approach, retrieval was about 19.54%. The success rate was 48.9% out of 45 procedures in the transverse approach and 40.5% out of 42 procedures in the vertical/Longitudinal approach. The most common reported post-operative complication in transverse type was atrophy 20% and pain 13.3% on other hand common complications recorded for vertical type, atrophy was about 17.2% and pain in12.6% of patients. Not much statistical significance was observed between the transverse and longitudinal approach in either of the outcomes whether it is success rate or post-op complications. Both approaches are influenced by the factors of surgeon expertise and certain other factors that include pre and postop hormonal therapy, baseline hormonal status, and ICSI.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.